Skip to main content

Table 1 Characteristics of studies included in the meta-analysis

From: Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis

Author

Year

Country

Tumor Type

Sample Size

Cat-off value

Follow-up (month)

SNHG6 expression

Detection Method

Outcome measures

Survival Analysis

HR estimated method

NOS

High

Low

LNM

DM

LNM

DM

An HX

2018

China

RCC

81

FC > 1

80(total)

32

NA

11

NA

qRT-PCR

OS

Univariate; multivariate

Directly

8

Cai G

2018

China

Glioma

58

median

60(total)

NA

NA

NA

NA

qRT-PCR

OS

Univariate

Indirectly

8

Chang L

2016

China

HCC

80

median

36(total)

NA

NA

NA

NA

qRT-PCR

OS/RFS

Univariate; multivariate

Directly

7

Li M

2017

China

CRC

74

median

58(median)

NA

NA

NA

NA

qRT-PCR

OS

Univariate; multivariate

Directly

6

Meng Q

2018

China

Glioma

71

median

60(total)

NA

NA

NA

NA

qRT-PCR

OS

Univariate

Indirectly

7

Wu Y

2018

China

OCCC

48

median

70(total)

10

10

8

17

qRT-PCR

OS/PFS

Univariate

Indirectly

7

Xu M

2019

China

CRC

120

median

90(total)

18

41

7

55

qRT-PCR

OS/DFS

Univariate; multivariate

Directly

8

Yan K

2017

China

GC

78

median

60(total)

21

13

19

21

qRT-PCR

OS

Univariate

Indirectly

8

Yu C

2019

China

CRC

141

median

60(total)

12

62

5

69

qRT-PCR

OS/RFS

Univariate; multivariate

Directly

6

Zhang YL

2019

China

ESCC

75

median

60(total)

31

31

13

31

qRT-PCR

OS

Univariate

Indirectly

8

Zheng LL

2018

China

osteosarcoma

58

mean

60(total)

NA

8

NA

23

qRT-PCR

OS

Univariate; multivariate

Directly

8

Zhu X

2019

China

osteosarcoma

30

median

60(total)

11

12

6

12

qRT-PCR

OS

Univariate

Indirectly

7

Zhu YK

2018

China

CRC

40

median

60(total)

16

13

5

19

qRT-PCR

OS

Univariate

Indirectly

8

  1. Notes: RCC renal cell carcinoma, HCC hepatocellular carcinoma, CRC colorectal cancer, OCCC ovarian clear cell carcinoma, GC gastric cancer, ESCC esophageal squamous cell carcinoma, qRT-PCR quantitative real-time PCR, OS overall survival, RFS relapse-free survival, PFS progression-free survival, DFS disease-free survival, NOS The Newcastle-Ottawa Scale, FC Fold-change